Live Quote · NASDAQNERVHealthcare· Biotechnology

Minerva Neurosciences, Inc.

$2.00▼ 5.66%($-0.12)
MKT CAP $99.67MNEXT EARNINGS Mar 10, 2027
50%
Bullish
TickerSpark Score
51/100
▌ Mixed
90
Valuation
40
Profitability
15
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NERV research report →

Analyst Price Target
$10.00+400.0% vs. today

Range $10 – $10

Analyst RatingBuy
5 Buy2 Hold0 Sell

Price Chart

-53.92% · this period
$8.07$5.04$2.00Nov 20May 26Nov 20
52-Week Range1% of range
Low
$1.96
Current
$2.00
High
$8.80